Individuals

Clinitians

Biopharma

Individuals who are either patients with IDs or those not formally diagnosed with an ID but at high risk of developing one or more IDs in the near future.

Clinicians and other health care practitioners responsible for the care of patients either with, or at risk of developing, IDs.

Biopharma companies developing anti-inflammatory therapeutics.